Ronald Blue Trust, Inc. Bausch Health Companies Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 88 shares of BHC stock, worth $770. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88
Previous 64
37.5%
Holding current value
$770
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
255Shares Held
254MCall Options Held
5.47MPut Options Held
16.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$304 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$258 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$232 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$137 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$114 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $3.17B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...